Ntla stock seeking alpha

NTLA | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for INTELLIA THERAPEUTICS INC (NTLA), including profile, stock chart, recent news and events, analyst opinions, and research reports. NTLA Intellia Therapeutics — Stock Price and Discussion ... Real-time trade and investing ideas on Intellia Therapeutics NTLA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Intellia Therapeutics, Inc. (NTLA) Company Profile & Facts ...

Intellia Therapeutics, Inc. - NTLA - Stock Price Today - Zacks

See NTLA stock predictions by 1 financial experts and find out if their Intellia Therapeutics stock forecast (NTLA) is more bullish in comparison to other stocks in the Healthcare sector. Intellia Therapeutics - investor relations The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts. Sangamo Therapeutics: Market Cap Is At A Bargain Relative ...

NTLA: Get the latest Intellia Therapeutics stock price and detailed information including NTLA news, historical charts and realtime prices.

NTLA Stock Price & Charts | Intellia Therapeutics In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Intellia Therapeutics - NTLA - Stock Price & News | The ... Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. NTLA Stock Quote - Intellia Therapeutics Inc. NTLA stock quote information – including stock price, key financials, stock charts and investing ideas containing NTLA. What We Offer. Individual Investors. Seeking Alpha (Wed, Feb 5) United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen. NTLA Stock Price, Forecast & News (Intellia Therapeutics)

8 brokerages have issued 12-month price objectives for Intellia Therapeutics' stock. Their forecasts range from $16.00 to $57.50. On average, they expect Intellia Therapeutics' stock price to reach $26.42 in the next twelve months. This suggests a possible upside of 121.4% from the stock's current price.

Dec 10, 2018 · And CRSP stock — along with NTLA and EDIT — sold off on the news. You’ll see that the Seeking Alpha story reporting the loss is also perpetuating the problem.

NTLA Chart - Stock Screener, Excel Addin, Stock Charts and ...

Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Tesla, 'Gene Editing' Stocks Under Pressure Look for NTLA to go higher from here. Sep 8, 2017 11:01 AM EDT Arcadia Biosciences Stock. SeekingAlpha